Get started
Author

Victoria Cannon

Observed name: Victoria A. Cannon
ORCID: 0009-0006-7736-8235
Observed ORCID: 0009-0006-7736-8235
OpenAlex ID: A5077451370
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2021 · James F Howard, Vera Bril, et al. · The Lancet Neurology · 744
Adiposity, Change in Adiposity, and Cognitive Decline in Mid‐ and Late Life
2017 · Nancy A. West, Seth T. Lirette, et al. · Journal of the American Geriatrics Society · 41
Multiplex Digital PCR Assay Targeting DNA Methylation for Early Detection of Cancer
2025 · Victoria Cannon, Jocelyn H. Wright, et al. · Methods in molecular biology · 1
Implementing STrAtegies for RelaTives of people with dementia (START) as a group: a service-level case study of collaboration between Talking Therapies and Memory Services
2024 · Victoria Cannon, Ronja Kuhn, et al. · The Cognitive Behaviour Therapist · 1
PDF
Pd27-08 Urology Bootcamp: Preliminary Results From a Pilot Simulation-based Curriculum
2019 · John Cooper*, Justin Rose, et al. · The Journal of Urology · 1
PDF
Tu1538: FUSOBACTERIUM NUCLEATUM AND ITS EFFECTS ON TREATMENT RESPONSE IN RECTAL CANCER
2022 · Marina Hanna, Ming Yu, et al. · Gastroenterology
Anti-MuSK Antibody Positive Myasthenia Gravis Patient Demographics, Symptomatology, and Treatment Responsiveness in the University of Southern California Neuromuscular Clinic: A Retrospective Analysis (2921)
2020 · Victoria Cannon, Said Beydoun, et al. · Neurology
Student Neurology Clerkship Improvement Project (“SNIP”) (P2.009)
2018 · Victoria Cannon, Emily Nonnemacher, et al. · Neurology
Works count: 8
Citation count: 788
H-index: 2
I10-index: 2
Year
Topic
Type